All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
-
Published:2024-02
Issue:
Volume:124
Page:104311
-
ISSN:0955-3959
-
Container-title:International Journal of Drug Policy
-
language:en
-
Short-container-title:International Journal of Drug Policy
Author:
Requena Maria-BernardaORCID,
Protopopescu CameliaORCID,
Stewart Ashleigh C.ORCID,
van Santen Daniela K.,
Klein Marina B.,
Jarrin Inmaculada,
Berenguer JuanORCID,
Wittkop LindaORCID,
Salmon Dominique,
Rauch Andri,
Prins Maria,
van der Valk Marc,
Sacks-Davis Rachel,
Hellard Margaret EORCID,
Carrieri Patrizia,
Lacombe KarineORCID
Reference45 articles.
1. HIV and women in the USA: What we know and where to go from here;Adimora;The Lancet,2021
2. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: A systematic review and meta-analysis;Aldridge;Lancet (London, England),2018
3. Women, drugs and HIV;Azim;International Journal of Drug Policy,2015
4. HIV's trajectory: Biomedical triumph, structural failure;Beletsky;American Journal of Public Health,2021
5. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study;Carrat;The Lancet,2019